AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Advertisement

Chronic conditions

Ensuring a patient-centred approach to care for people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Module 2 of a 2-part series: Providing care for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) requires a patient-centred approach with a focus on quality of life and incorporating the multidisciplinary team. This second module on ME/CFS provides detail on making a differential diagnosis, the non-core symptoms of ME/CFS, management in specific populations, and the development of a patient-centred treatment plan.

Continuous glucose monitoring and flash glucose monitoring in type 2 diabetes

Continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) are new technologies that can assist in achieving effective glycaemic control in type 2 diabetes. This module explores the role of CGM and Flash GM in providing effective diabetes care, and provides guidance on interpreting glucose profiles and setting personalised targets.

IN Control clinical audit: INsulin INitiation and INtensification to avoid clinical INertia

Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.

Managing epilepsy in older people: Optimising outcomes in general practice

Epilepsy is a common problem for older adults, and has a greater impact in older people compared to younger populations. This module describes key differences between the causes and presentation of epilepsy in older versus younger people, as well as special considerations for prescribing antiseizure drugs for older people. This two-hour activity contains a online learning module as well as a patient review exercise involving preparation of a GP Management Plan for a patient.

T2D injectables: 1. Intensifying to first injectable therapy in uncomplicated type 2 diabetes

This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

Pages